Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment (2023)
- Authors:
- USP affiliated authors: DAGLI, MARIA LUCIA ZAIDAN - FMVZ ; GOMES, CRISTINA DE OLIVEIRA MASSOCO SALLES - FMVZ ; KFOURY JUNIOR, JOSÉ ROBERTO - FMVZ ; SORKHABI, PARVIZ AZIMNASAB - FMVZ ; ASL, MARYAM SOLTANI - FMVZ
- Unidade: FMVZ
- DOI: 10.1007/s11033-023-08469-3
- Subjects: NEOPLASIAS; ENZIMAS; IMUNOSSUPRESSÃO
- Keywords: IDO; kynurenine; IDO inhibitor; immunosuppression; cancer; tumor microenvironment
- Language: Inglês
- Imprenta:
- Source:
- Título: Molecular Biology Reports
- ISSN: 0301-4851
- Volume/Número/Paginação/Ano: v. 50, p. 6133-6145, 2023
- Status:
- Artigo possui acesso gratuito no site do editor (Bronze Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
AZIMNASAB‐SORKHABI, Parviz et al. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports, v. 50, p. 6133-6145, 2023Tradução . . Disponível em: https://doi.org/10.1007/s11033-023-08469-3. Acesso em: 06 maio 2026. -
APA
Azimnasab‐sorkhabi, P., Soltani‐asl, M., Yoshinaga, T. T., Dagli, M. L. Z., Gomes, C. de O. M. -S., & Kfoury Junior, J. R. (2023). Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment. Molecular Biology Reports, 50, 6133-6145. doi:10.1007/s11033-023-08469-3 -
NLM
Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Dagli MLZ, Gomes C de OM-S, Kfoury Junior JR. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment [Internet]. Molecular Biology Reports. 2023 ; 50 6133-6145.[citado 2026 maio 06 ] Available from: https://doi.org/10.1007/s11033-023-08469-3 -
Vancouver
Azimnasab‐sorkhabi P, Soltani‐asl M, Yoshinaga TT, Dagli MLZ, Gomes C de OM-S, Kfoury Junior JR. Indoleamine-2,3 dioxygenase: a fate-changer of the tumor microenvironment [Internet]. Molecular Biology Reports. 2023 ; 50 6133-6145.[citado 2026 maio 06 ] Available from: https://doi.org/10.1007/s11033-023-08469-3 - The combination of IDO and AHR blockers reduces the migration and clonogenicity of breast cancer cells
- IDO blockade negatively regulates the CTLA-4 signaling in breast cancer cells
- Landscape of unconventional γδ T cell subsets in cancer
- Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) as an undetermined tool in tumor cells
- The impact of leptin and its receptor polymorphisms on type 1 diabetes in a population of northwest Iran
- The role of IDO enzyme on the expression of CTLA-4 immune checkpoint on the T lymphocyte cells in mammary câncer
- Evaluation the role of the IDO-kyn-AHR pathway on T cells and macrophages in the breast tumor microenvironment
- Targeting canine mammary neoplastic epithelial cells with a reengineered anthrax toxin: first study
- Inhibitory effects of a reengineered anthrax toxin on canine and human osteosarcoma cells
- Intratumoral (Poly-ICLC) therapy for dogs with advanced cancers: first report on clinical effectiveness, quality of life, and adverse events
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 |
DAG_1402_3136926_R.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
